Keren David
Rehovot, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosis.
Journal: PLoS biology
Published: May 28, 2025
CD47 and thrombospondin-1 contribute to immune evasion by Porphyromonas gingivalis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 13, 2024
CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer.
Journal: Cell reports
Published: February 01, 2024
CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells.
Journal: PLoS biology
Published: December 21, 2023
CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma.
Journal: JCI insight
Published: July 24, 2023
CD74 as a regulator of transcription in normal B cells.
Journal: Cell reports
Published: August 10, 2022
Polysome-CAGE of TCL1-driven chronic lymphocytic leukemia revealed multiple N-terminally altered epigenetic regulators and a translation stress signature.
Journal: eLife
Published: February 08, 2022
CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma.
Journal: JCI insight
Published: June 29, 2020
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5.
Journal: Nature communications
Published: April 17, 2020
CD74 is a regulator of hematopoietic stem cell maintenance.
Journal: PLoS biology
Published: April 08, 2020
Rapid enzymatic burn debridement: A review of the paediatric clinical trial experience.
Journal: International wound journal
Published: March 25, 2020
Minimally invasive burn care: a review of seven clinical studies of rapid and selective debridement using a bromelain-based debriding enzyme (Nexobrid®).
Journal: Annals of burns and fire disasters
Published: June 07, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026